Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T Chylack

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
The British Journal of Ophthalmology|March 1, 1989
Allopurinol use and the risk of cataract formationW K Clair, L T Chylack, E F Cook, et al.
American Journal of Ophthalmology|June 11, 1975
Ocular manifestations of juvenile rheumatoid arthritisL T Chylack, D C Bienfang, A R Bellows, et al.
Ophthalmology|September 1, 1979
Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lensesL T Chylack, H F Henriques, H M Cheng, et al.
The Journal of Biological Chemistry|May 25, 1981
Nonenzymatic glycosylation of bovine lens crystallins. Effect of agingS H Chiou, L T Chylack, W H Tung, et al.
Diabetes|April 1, 1986
The effect of oxidation on sorbitol pathway kineticsP A Barnett, R G González, L T Chylack, et al.
Current Eye Research|December 1, 1987
Quantitative detection of the molecular changes associated with early cataractogenesis in the living human lens using quasielastic light scatteringG B Benedek, L T Chylack, T Libondi, et al.
Investigative Ophthalmology & Visual Science|February 7, 2001
LEDGF: survival of embryonic chick retinal photoreceptor cellsM Nakamura, D P Singh, E Kubo, et al.
Cell and Tissue Research|August 22, 2001
Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (ledgf/p75) and p52, in the nucleusY Nishizawa, J Usukura, D P Singh, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 1, 1993
Lovastatin and the human lens; results of a two year study. The MSDRL Study GroupL T Chylack, G Mantell, J K Wolfe, et al.
Investigative Ophthalmology & Visual Science|August 1, 1980
Differences in the susceptibility of various aldose reductases to inhibition. IIP F Kador, J H Kinoshita, W H Tung, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
The British Journal of Ophthalmology|March 1, 1989
Allopurinol use and the risk of cataract formationW K Clair, L T Chylack, E F Cook, et al.
American Journal of Ophthalmology|June 11, 1975
Ocular manifestations of juvenile rheumatoid arthritisL T Chylack, D C Bienfang, A R Bellows, et al.
Ophthalmology|September 1, 1979
Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lensesL T Chylack, H F Henriques, H M Cheng, et al.
The Journal of Biological Chemistry|May 25, 1981
Nonenzymatic glycosylation of bovine lens crystallins. Effect of agingS H Chiou, L T Chylack, W H Tung, et al.
Diabetes|April 1, 1986
The effect of oxidation on sorbitol pathway kineticsP A Barnett, R G González, L T Chylack, et al.
Current Eye Research|December 1, 1987
Quantitative detection of the molecular changes associated with early cataractogenesis in the living human lens using quasielastic light scatteringG B Benedek, L T Chylack, T Libondi, et al.
Investigative Ophthalmology & Visual Science|February 7, 2001
LEDGF: survival of embryonic chick retinal photoreceptor cellsM Nakamura, D P Singh, E Kubo, et al.
Cell and Tissue Research|August 22, 2001
Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (ledgf/p75) and p52, in the nucleusY Nishizawa, J Usukura, D P Singh, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 1, 1993
Lovastatin and the human lens; results of a two year study. The MSDRL Study GroupL T Chylack, G Mantell, J K Wolfe, et al.
Investigative Ophthalmology & Visual Science|August 1, 1980
Differences in the susceptibility of various aldose reductases to inhibition. IIP F Kador, J H Kinoshita, W H Tung, et al.
Pageof 16